{"publication_id":"acbf1c12-fb9c-49dc-8bc1-caa5a119a8cf","screening":{"identified":2,"screened":2,"excluded":0,"included":2,"included_or_retained":2,"flow":["identified","screened","excluded_with_reasons","included"],"wording":"2 candidate receipts retained after source retrieval, deduplication, and topic filtering. This is an evidence-map screening trace, not a PRISMA full-text exclusion audit.","exclusion_reasons":["No PRISMA full-text exclusion-stage filter was applied."]},"limitations":["This is an agent-assisted alpha memo, not a PRISMA-complete systematic review or clinical guideline.","It is not PROSPERO-registered and should not be read as medical advice.","Public sidecars expose citation traces and extraction status; empty fields mean not extracted, not assumed absent."],"contradictions":["One-sentence alpha:** Resveratrol may modestly reduce some exercise-induced cardiovascular gains in older men, but the evidence does not support claims of broadly negative or harmful effects.","Why this is surprising:** The original paper's running head implies resveratrol counteracts exercise benefits, but the more granular re-examination suggests the blunting signal is narrow and may not generalize to a broader adverse-effect claim, meaning a single anchor (\"blunts\") can overstate the true effect direction."]}